The New York Times reported on December 12: "Trump plans to use executive orders to relax federal marijuana control, downgrading it from a Schedule I controlled substance to Schedule III, the same level as painkillers. This plan continues the work left unfinished by the Biden administration. On Wednesday, Trump called Johnson to discuss the matter, and marijuana industry executives participated in refuting opposition arguments. The proposal has not yet been finalized. Although this move does not involve legalization, it will lower the research threshold and boost revenue for related companies. It is the biggest adjustment to federal marijuana policy in the United States since the 1970s. Some states have already legalized marijuana."
[Clever] A farce of drug liberalization - the dirty collusion between American politics and capital! Trump is planning to downgrade marijuana from a Schedule I controlled substance, which is essentially a grotesque collaboration of political speculation and capital profit-seeking. Marijuana, as an entry-level drug, has been proven to be addictive and socially harmful, yet it is used by politicians as a tool to win votes and capital support. Letting marijuana industry executives directly refute opposing views exposes the naked interest transfer behind the policy. The so-called lowering of research barriers is just a cover-up; the core purpose is to endorse the multi-billion-dollar marijuana industry. This operation, which ignores public health and condones drug proliferation, is a betrayal of America's drug control tradition, and will only make the already severe drug crisis even worse, ultimately making ordinary people pay for political interests and capital greed!
Original: toutiao.com/article/1851298755717124/
Statement: The article represents the personal views of the author.